Pay in 4 interest-free payments of $5.03 Learn more
Ships within 48 hours · Estimated delivery Aug 7 - Aug 12
hospitalization required Maintenance of Remission: Immunomodulators (azathioprine, 6-MP, methotrexate) for steroid-dependent or frequently-relapsing disease Biologic monotherapy or combination therapy (biologic + immunomodulator) for moderate-to-severe disease Step-up or top-down approach based on disease severity, patient risk factors, and prior therapy Biologic Therapy Targets: TNF-: Infliximab (IV), adalimumab (SC), certolizumab pegol (SC) IL-12/23: Ustekinumab (IV induction, SC maintenance) Integrin: Vedolizumab (IV) IL-23: Risankizumab (IV induction, SC maintenance) JAK inhibition: Upadacitinib (oral) Surgical Management Surgery is indicated in approximately 7080% of patients with Crohns disease over their lifetime, per StatPearls
Studies published within the past decade were prioritized to ensure the inclusion of current clinical practices and evolving pharmacologic trends
REFERENCES Are you passionate about nutrition
Liang Y, et al
This is one of the most common and frustrating experiences men report after starting test
Look for labels that say No GMOs, No Gluten, or No Artificial Ingredients to ensure youre getting a clean, effective formula
US$ 25.32
US$ 24.27
US$ 26.22
US$ 26.63
